Assessing prostate cancer growth with citrate measured by intact tissue proton magnetic resonance spectroscopy - Abstract

Background:Annual PSA tests have led to a significant increase in the number of prostate cancer (PCa) cases diagnosed.

This increased incidence has led to overtreatment of many patients, as current pathology often cannot distinguish latent from aggressive PCa. Studies have shown that the depletion of zinc in prostate cells correlated with cell-line growth rates, and may therefore relate to the progression of PCa. Furthermore, as zinc is normally an inhibitor of citrate oxidation, the reduction of zinc in PCa may cause a decrease in citrate secretion levels in the glandular epithelia of PCa patients.

Methods: Using high-resolution magic angle spinning proton magnetic resonance spectroscopy followed by quantitative histopathology, we investigate unit histo-benign prostate epithelial citrate concentrations in intact tissue samples obtained from 18 patients with pre-surgical PSA values less than 20‚ÄČng/ml. Using these data, we evaluate correlations between citrate concentrations and PSA velocities, densities and blood percent-free PSA.

Results: We observe different linear patterns between citrate concentrations and histo-benign glandular epithelia from patients of different PSA velocities. More importantly, we obtain a significant correlation between PSA velocity, density and percent-free PSA, and citrate concentrations in unit volume of histo-benign epithelial glands of the peripheral zone.

Conclusions: Low levels of citrate in unit volume represent rapidly increasing PSA values, and, therefore, may be used as an indicator of fast-growing PCa. Thus, tissue samples obtained at the time of biopsy may be evaluated for their citrate concentrations for the prediction of PCa growth rates, allowing for the implementation of alternative treatment options and reducing overtreatment.

Written by:
Dittrich R, Kurth J, Decelle EA, Defeo EM, Taupitz M, Wu S, Wu CL, McDougal WS, Cheng LL. Are you the author?
Departments of Radiology, Pathology and Urology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Charité Universitätsmedizin, Berlin, Germany.

Reference: Prostate Cancer Prostatic Dis. 2012 Jan 31. Epub ahead of print.
doi: 10.1038/pcan.2011.70

PubMed Abstract
PMID: 22289782